Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

12 March 2024: Clinical Research

Maternal Vaccination in Pregnancy: An Assessment of Influenza, Pertussis, and COVID-19 Vaccination Rates in Cracow, Poland

Julia Jurga ABCDEF* , Gabriela Mierzwa ABDEF , Justyna Agnieszka Kuciel ABDEF , Magdalena Kołak ADE , Andrzej Jaworowski ADE , Hubert Huras ADE

DOI: 10.12659/MSM.943304

Med Sci Monit 2024; 30:e943304

Table 2 Study group characteristics.

CharacteristicN=205InfluenzaPertussisCOVID-19
Vaccinatedn=25Unvacci-natedn=180PVaccinatedn=48Unvacci-natedn=157PVaccinated ≥2 dosesn=126Unvacci-nated/Vaccinated with 1 dosen=79P
Age* 33.9±3.632.5±4.632.4±3.732.8±4.832.7±4.632.6±4.4
Primary0 (0.0%)1 (0.6%)0 (0.0%)1 (0.6%)0 (0.0%)1 (1.3%)
Secondary1 (4.0%)12 (6.7%)2 (4.2%)11 (7.0%)7 (5.6%)6 (7.6%)
Vocational1 (4.0%)38 (21.1%)5 (10.4%)34 (21.7%)25 (19.8%)14 (17.7%)
Higher23 (92.0%)129 (71.6%)41 (85.4%)111 (70.7%)94 (74.6%)58 (73.4%)
White-collar worker25 (100.0%)124 (68.9%)43 (89.5%)106 (67.5%)99 (78.5%)50 (63.3%)
Blue-collar worker0 (0.0%)44 (24.4.%)2 (4.2%)42 (26.7%)21 (16.7%)23 (29.1%)
Both0 (0.0%)10 (5.6%)3 (6.3%)7 (4.5%)6 (4.8%)4 (5.1%)
Unemployed0 (0.0%)2 (1.1%)0 (0.0%)2 (1.3%)0 (0.0%)2 (2.5%)
Rural area5 (20.0%)60 (33.3%)10 (20.8%)55 (35.0%)36 (28.5%)29 (36.7%)
Cities with0 (0.0%)13 (7.3%)2 (4.2%)11 (7.0%)8 (6.3%)5 (6.3%)
Cities with 20 000–100 000 inhabitants0 (0.0%)22 (12.2%)4 (8.3%)18 (11.5%)8 (6.3%)14 (17.7%)
Cities with >100 000 inhabitants20 (80.0%)85 (47.2%)32 (66.7%)73 (46.5%)74 (58.7%)31 (39.3%)
Thyroid disease7 (28.0%)44 (24.4.%)12 (25.0%)39 (24.8%)31 (24.6%)20 (25.3%)
Diabetes mellitus1 (4.0%)4 (2.2%)1 (2.1%)4 (2.5%)3 (2.4%)2 (2.5%)
Heart disease1 (4.0%)4 (2.2%)1 (2.1%)4 (2.5%)2 (1.6%)3 (3.8%)
Lung disease1 (4.0%)2 (1.1%)1 (2.1%)2 (1.3%)2 (1.6%)1 (1.3%)
Gynecological disease1 (4.0%)4 (2.2%)2 (4.2%)3 (1.9%)3 (2.4%)2 (2.5%)
Gravidity** 2.0 (1.0;3.0)2.0 (1.0;3.0)1.5 (1.0;2.0)2.0 (1.0;3.0)2.0 (1.0;3.0)2.0 (1.0;3.0)
Parity** 2.0 (1.0;2.0)2.0 (1.0;2.0)1.0 (1.0;2.0)2.0 (1.0;2.0)2.0 (1.0;2.0)2.0 (1.0;3.0)
Primipara10 (40.0%)81 (45.0%)30 (62.5%)61 (38.9%)62 (49.2%)29 (36.7%)
Multipara15 (60.0%)99 (55.0%)18 (37.5%)96 (61.1%)64 (50.8%)50 (63.3%)
16 (64.0%)105 (58.3%)28 (58.3%)93 (59.2%)77 (61.1%)44 (55.7%)
1–3 years4 (16.0%)23 (12.8%)11 (22.9%)16 (10.2%)15 (11.9%)12 (15.2%)
>3 years3 (12.0%)11 (6.1%)3 (6.3%)11 (7.0%)10 (8.0%)4 (5.1%)
Unplanned pregnancy2 (8.0%)41 (22.8%)6 (12.5%)37 (23.6%)24 (19.0%)19 (24.0%)
Assisted reproductive technology4 (16.0%)15 (8.3%)8 (16.7%)11 (7.0%)14 (1.1%)5 (6.3%)
* Data presented as mean and standard deviation.
** Data presented as median and first and third quartile (Q1–Q3).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750